Braun, Jürgen http://orcid.org/0000-0002-9156-5095
Buehring, Bjoern
Baraliakos, Xenofon
Gensler, Lianne S.
Porter, Brian
Quebe-Fehling, Erhard
Haemmerle, Sibylle
Funding for this research was provided by:
Novartis Pharma AG
Article History
Received: 22 December 2020
Accepted: 1 December 2021
First Online: 13 December 2021
Declarations
:
: All clinical studies were conducted in compliance with the Declaration of Helsinki, International Council for Harmonization Guidelines for Good Clinical Practice and local country regulations and were approved by the institutional review board or independent ethics committee (Supplementary TableInternalRef removed) at each participating centre. All patients provided written informed consent to participate in the respective studies.
: Not required.
: JB: Grant/research support from: Abbvie (Abbott), Amgen, BMS, Boehringer, Celgene, Celltrion, Centocor, Chugai, Medac, MSD (Schering-Plough), Mundipharma, Novartis, Pfizer (Wyeth), Roche, Sanofi-Aventis and UCB, Eli Lilly consultant for: Abbvie (Abbott), Amgen, BMS, Boehringer, Celgene, Celltrion, Centocor, Chugai, EBEWE Pharma, Medac, MSD (Schering-Plough), Mundipharma, Novartis, Pfizer (Wyeth), Roche, Sanofi-Aventis and UCB, Eli Lilly and received speakers bureau fees from: Abbvie (Abbott), Amgen, BMS, Boehringer, Celgene, Celltrion, Centocor, Chugai, EBEWE Pharma, Medac, MSD (Schering-Plough), Mundipharma, Novartis, Pfizer (Wyeth), Roche, Sanofi-Aventis and UCB pharma, Eli Lilly.BB: Grant/research support from: Kinemed, Extendicare Foundation, Lilly, GE/Lunar and MSD; consultant for: GE/Lunar, Gilead, Theramex, UCB; received speakers bureau fees from UCB, MSD, Biogen, Sanofi Genzyme; Travel support from Janssen, UCB, Gilead, AbbVie.XB: Grant/research support from: AbbVie, Novartis, Consultant for: AbbVie, BMS, Celgene, Chugai, Merck, Novartis, Pfizer, UCB, Werfen, Speakers bureau: AbbVie, BMS, Celgene, Chugai, Merck, Novartis, Pfizer, UCB.LSG: Grant/research support from: Novartis, Pfizer and UCB, Consultant for: AbbVie, Eli Lilly, GSK, Novartis and UCB.BP: Employee of Novartis and owns Novartis stock.EQF: Employee of Novartis and owns Novartis stock.SH: Employee of Novartis and owns Novartis stock.